United Arab Emirates vs Uzbekistan: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
United Arab Emirates
94.0%
in 2024
Uzbekistan
94.0%
in 2024
United Arab Emirates rank
34th
Uzbekistan rank
34th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- United Arab Emirates
- Uzbekistan
How they compare
United Arab Emirates currently reports 94.0% against 94.0% in Uzbekistan, a difference of 0.0%.
The two have swapped places 2 times across 8 shared years of data; in 2017 it was Uzbekistan ahead.
United Arab Emirates ranks 34th and Uzbekistan ranks 34th of 146 countries.
Uzbekistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | United Arab Emirates | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.0% | 98.0% | 0.0% | — |
| 2020s | 92.4% | 96.6% | 4.2% | Uzbekistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, United Arab Emirates or Uzbekistan?
- United Arab Emirates, at 94.0% against 94.0% in Uzbekistan as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between United Arab Emirates and Uzbekistan?
- 0.0%, with United Arab Emirates ahead.
- How many years of comparable data are there for United Arab Emirates and Uzbekistan?
- 8 years are reported by both, from 2017 to 2024.
- How do United Arab Emirates and Uzbekistan rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- United Arab Emirates ranks 34th and Uzbekistan ranks 34th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.